CERE - Why Cerevel Therapeutics Holdings Is Moving After-Hours | Benzinga
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading higher in Wednesday's after-hours session after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity value of approximately $8.7 billion.
What To Know: The definitive agreement, under which AbbVie will acquire Cerevel Therapeutics, was announced after the close of the market ...